CDTAF yields 7812.50% · JNJ yields 2.13%● Live data
📍 CDTAF pulled ahead of the other in Year 1
Combined, CDTAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CDTAF + JNJ for your $10,000?
infinitii ai inc. operates as an industrial Internet of Things and big data as a service company in Canada and the United States. The company operates in three segments: Data Services, Data Hosting, and Sale of Environmental Sensors. It offers collection, storage, and analytic solutions for data-centric organizations. The company's products and solutions enable clients to analyze and model environmental data through a network of custom sensor arrays combined with Software-as-a-Service-based monitoring, reporting, and predictive modeling applications; and provides the scalability required to monitor data collected by government and industrial customers. Its product portfolio includes predictive analytics software for industrial and Smart City infrastructure applications that works on time-series data; and software performs real-time analysis, checks flow monitoring status, sets alarms through a single interface, and accepts various types of data from source, as well as offers predictive and prescriptive analytics. The company was formerly known as Carl Data Solutions Inc. and changed its name to infinitii ai inc. in October 2022. infinitii ai inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.
Full CDTAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.